26+ years of pharmaceutical excellence meets cutting-edge AI innovation
Founder & Managing Director
MBBS, BSc (Hons), MBA, FFPM
Dr. Anzal Qurbain is a GMC registered pharmaceutical physician with a full license to practice and revalidate annually, accompanied by an Executive MBA from London Business School.
With over 26 years of hands-on experience in the pharmaceutical industry, he has navigated diverse roles encompassing Medical Affairs, Clinical Development, Safety Risk Management, and Regulatory Affairs across both local and global senior management positions.
As a seasoned ABPI Final Signatory, Dr. Qurbain brings a comprehensive understanding of the industry's intricacies on a global scale — from blockbuster product launches to complex Phase 3/4 study leadership.
Dr. Qurbain's journey has been characterised by strong commercial acumen, instrumental in driving the success of blockbuster product launches. He has spearheaded high-profile launches, led pivotal studies, and facilitated advisory boards — shaping strategies that resonate with both healthcare professionals and patients.
Senior leadership positions at leading pharmaceutical companies
Global Medical Affairs Signatory for Respiratory Biologics. Global Clinical Medical Director (CNS, Anti-infectives, Pain) — Signal Detection, Due Diligence and portfolio safety risk management.
Final ABPI Signatory, focusing on CVS and Anaemia, ensuring regulatory compliance and overseeing clinical practices.
Associate Medical Director, contributing to advancements in Rare Diseases and Haemophilia.
European Medical Affairs Director, overseeing CNS programmes across EU/ROW, driving alignment and innovation.
Global Clinical Safety and Medical Monitor, enabling oversight of clinical trials, ensuring patient safety and regulatory alignment.
Senior Medical Advisor and Final ABPI Signatory — Immunology, Rare Diseases, Respiratory, Dermatology, and MS.
Immunology Final Signatory and Medical Therapy Area Head for Immunology, guiding strategic development.
Senior Medical Advisor in Respiratory, Anticoagulation, and Smoking Cessation, enhancing the treatment landscape.
Medical Therapy Area Head for Respiratory/CNS, guiding strategic development and launch excellence.
Country Medical Director & Deputy MD (CNS, Psychiatry, Aesthetics). QPPV — MHRA inspection lead for GVP, GCP, GLP.
Drug Safety Physician (Oncology, Dermatology, Gastroenterology) — Post marketing and Clinical Safety Risk Management.
Medical Affairs and Education Leader, fostering innovation in Respiratory and Lung Infections.
Extensive expertise across multiple therapeutic areas, enabling adaptability across diverse pharmaceutical portfolios
Psychiatry, Pain Management, Neurodegenerative Diseases
Haemophilia, Metabolic Disorders, Ultra-rare Conditions
Rheumatology, IBD, Psoriasis, Autoimmune Disorders
Asthma, COPD, Biologics, Lung Infections
Inflammatory Skin Conditions, Aesthetics
Anticoagulation, Heart Failure, CVS, Anaemia
Diabetes, Metabolic Syndrome, Endocrine Disorders
Infectious Diseases, Antivirals, HIV Treatment
Solid Tumours, Haematological Malignancies
Smoking Cessation, Preventive Medicine
IBD, Hepatology, GI Therapeutics
Medical Aesthetics, Dermatological Innovation
Access to 50+ pharmaceutical industry specialists across therapeutic areas and functional disciplines
Beyond our core team, MedicalGoGo maintains close relationships with an extensive network of pharmaceutical industry experts. This allows us to rapidly scale resources to match your project needs — whether you require specialised therapeutic area expertise, multilingual medical writing, or complex data analysis capabilities.
Our network includes former Medical Directors, Clinical Development leads, Regulatory Affairs specialists, Market Access strategists, and KOL relationship managers from companies including Pfizer, Merck, Roche, Johnson & Johnson, AbbVie, Amgen, Novartis, GSK, Sanofi, and UCB.
MedicalGoGo was founded to address a critical gap Dr. Qurbain observed throughout his 26-year career: the disconnect between cutting-edge AI capabilities and practical Medical Affairs execution.
Having led Medical Affairs and Marketing teams at Top 20 pharmaceutical companies, Dr. Qurbain experienced firsthand the challenges of delivering high-quality scientific content at the speed of business. Content backlogs stretched for months. Strategic initiatives stalled awaiting evidence synthesis. KOL materials required endless revision cycles.
Today, MedicalGoGo combines deep pharmaceutical expertise with proprietary AI-enhanced workflows to deliver 40–60% faster turnaround times without compromising quality. We're not just consultants — we're your strategic Medical Affairs and Medico-Marketing partners, powered by AI innovation and backed by 26 years of real-world pharmaceutical experience.
We preserve scientific rigour and regulatory compliance while dramatically accelerating delivery timelines and reducing costs.
Let's discuss how MedicalGoGo can support your Medical Affairs and Marketing objectives.
Get in Touch